Cholestyramine
NDC 68094-906, Cholestyramine, powder, for suspension, from Precision Dose, Inc..
- Product NDC
- 68094-906
- Status
- Listed
- Labeler
- Precision Dose, Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209599
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68094-906 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/4.8g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68094-906-10 | 68094090610 | 201.6 g in 1 CAN (68094-906-10) |
| 68094-906-20 | 68094090620 | 60 POUCH in 1 CARTON (68094-906-20) / 4.8 g in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/129fa522-b66b-4bb1-9ac6-74f98d93a86fNADAC price for package 68094090610
GET /v1/drugs/nadac/68094090610NADAC price for package 68094090620
GET /v1/drugs/nadac/68094090620
Use it
Look up 68094-906 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68094-906 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68094-906. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.